ORYZON to Give Updates on Corporate Progress in February-March

• BIO CEO & Investor Conference 2023

• IASLC 2023 Targeted Therapies of Lung Cancer Meeting
• 16th Annual European Life Sciences CEO Forum
• Cancer Epigenetics Institute Symposium: From Genes to Chromatin to Therapeutics
• BioCapital Europe 2023
• BIO-EUROPE Spring 2023
• SmallCap Event
  

MADRID, Spain and BOSTON, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give an update on corporate progress at several international events on February-March.

Oryzon will participate at the 25^th BIO CEO & Investor Conference, which will be held at the New York Marriot Marquis in New York (USA) on February 6-9. Click on link for more info about the BIO CEO & Investor Conference 2023

Oryzon’s medical team will attend the IASLC 2023 Targeted Therapies of Lung Cancer Meeting, which will be held virtually and on site at the Fairmont Miramar in Santa Monica (USA) on February 22-25. Click on link for more info about the IASLC 2023 Targeted Therapies of Lung Cancer Meeting

Oryzon has been invited to participate at the 16th Annual European Life Sciences CEO Forum 2023, which will be held on March 1-2 at the Hilton Zurich Airport Hotel in Zurich (Switzerland). The company will participate as panelist in the “Neuro Advances Panel” that will be held on March 1 at 16:30 CET. Click on link for more info about the 16^th Annual European Life Sciences CEO Forum 2023

Oryzon will attend the Cancer Epigenetics Institute Symposium: From Genes to Chromatin to Therapeutics 2023 hosted by the Cancer Epigenetics Institute and The Fox Chase Cancer Center, which will be held at the Franklin Institute in Philadelphia (USA) on March 2. Click on link for more info about the Cancer Epigenetics Institute Symposium: From Genes to Chromatin to Therapeutics 2023

Oryzon has been invited to participate at BioCapital Europe 2023, which will take place at the Hotel Sofitel Legend the Grand Amsterdam in Amsterdam (The Netherlands) on March 9, where the company will provide a corporate update at 15:00 CET. Click on link for more info about the BioCapital Europe 2023

Oryzon will attend the BIO-EUROPE Spring 2023 conference, which will be held at the Messe Basel in Basel (Switzerland) on March 20-22, where the company will hold one-to-one meetings with pharmaceutical companies and global investors. Click on link for more info about the Bio-Europe Spring 2023